The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

Following Fernando Mendoza's Heisman Trophy acceptance speech, a 2-year-old colt was dubbed Mendoza to carry a name meant to ...

The Kentucky Humane Society launched a fertility control program using PZP to stabilize free-roaming horse populations across ...

The St Paul police horse that grew ill recently has died, his owner announced, saying his death was “heartbreaking” ...

Veterinary team develops molecular test to find hidden equine herpesvirus infections before they spread to other animals.

The Foundation for the Horse has awarded $5,000 research career awards to two exceptional equine graduate investigators in ...

The horse appears listless, eats less than usual, or repeatedly shows mild colic symptoms–especially after feeding or during ...

According to the Equine Disease Communication Center, a recent outbreak of EHV-1, associated with the Women’s Professional ...

Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...

Austral Resources (ASX: AR1) demonstrated operational resilience by exceeding its **Q4** copper production guidance despite ...